How to Evaluate Your ML Model Before Series B Due Diligence
What investors ask about AI models during Series B due diligence - and how to prepare model validation documentation, bias testing, and performance benchmarks before the process starts.
Series B due diligence has an AI problem. Investors have learned from the first wave of AI startups that a high accuracy number on a company-provided test set tells them almost nothing about real-world model performance. Technical due diligence on AI companies now routinely includes questions that most founding teams are not prepared for.
What Investors Ask About Your AI Model
Based on the due diligence questions we have helped Series A and B companies prepare for, the standard questions are:
Performance validation:
- What is your model’s performance on a holdout test set not used during training?
- How does your model perform on the specific customer use cases that drive your revenue?
- What is the performance baseline you are comparing against?
Bias and fairness:
- Has your model been evaluated for demographic bias? Which protected characteristics were tested?
- If your model makes decisions that affect individuals, what is your bias monitoring methodology?
- Has anyone outside your team validated the bias evaluation?
Robustness and reliability:
- How does the model perform on out-of-distribution inputs?
- What happens at edge cases? What is the failure mode when the model is wrong?
- How does model performance degrade as production data drifts from training data?
MLOps and monitoring:
- How do you detect when model performance has degraded in production?
- How quickly can you retrain and redeploy when drift is detected?
- What is your rollback procedure if a new model version underperforms?
Why Most Series A Companies Fail This Scrutiny
The typical Series A AI company has:
- An internal test set created by the same team that built the model (subject to selection bias)
- A single accuracy metric reported at the aggregate level (no subgroup analysis)
- No formal bias evaluation
- Monitoring that tracks infrastructure health but not model quality
- No documented rollback procedure that has been tested
None of this is negligence - it’s the natural state of a company moving fast to build a product. But it creates a due diligence vulnerability.
How to Prepare
Six months before your Series B process:
Commission an independent model validation. Get an external evaluation of your model performance on a test set you didn’t construct. The word “independent” matters - investors discount self-reported benchmarks.
Run a bias audit. Even if your product doesn’t involve protected characteristics directly, understanding your model’s performance across demographic subgroups is now a standard due diligence question.
Document your monitoring. Can you show, concretely, how you would detect a model degradation in production and how you would respond?
Establish a performance baseline. What were you replacing? How much better is your AI than the previous approach?
Model validation covers the model layer. If your product is a GenAI application built on top of an LLM, investors increasingly ask about the application layer too, so it is worth pairing model validation with genai.qa’s application-layer testing for red-teaming, RAG evaluation, and agent safety before you enter due diligence.
The deliverable investors want to see:
A model validation report from an independent third party - covering methodology, test set composition, evaluation metrics across subgroups, bias findings, and a performance comparison to baseline.
Book a free scope call to prepare your model validation documentation before your fundraising process starts.
Frequently Asked Questions
What do Series B investors ask about AI models during due diligence?
Investors typically ask about independent holdout test set performance, demographic bias evaluation, out-of-distribution robustness, drift detection methodology, and rollback procedures. They also ask whether anyone outside your team validated the evaluation - self-reported benchmarks on company-constructed test sets are now routinely discounted by technical due diligence teams.
When should I commission an independent model validation before fundraising?
Commission independent validation at least six months before your Series B process starts. This gives time to run the bias audit, document monitoring procedures, establish performance baselines, and produce the third-party validation report that investors expect to see - rather than scrambling to produce documentation during an active due diligence process.
Why do investors discount self-reported AI benchmarks?
Internal test sets are typically created by the same team that built the model, introducing selection bias - the team naturally tests what they expect to work. Single aggregate accuracy metrics hide subgroup performance gaps. Investors have learned from the first wave of AI startups that company-provided benchmarks often fail to predict real-world performance, so independent third-party validation is now standard.
What does an independent model validation report cover?
A complete model validation report covers evaluation methodology, test set composition and how it was constructed, performance metrics broken out by subgroup, bias findings across protected characteristics, robustness testing results, and a performance comparison to the pre-AI baseline. This document is the primary deliverable investors want to see from AI technical due diligence.
Complementary NomadX Services
Ship AI You Can Trust.
Book a free 30-minute AI QA scope call with our experts. We review your model, data pipeline, or AI product - and show you exactly what to test before you ship.
Talk to an Expert